Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | -17.01%125.43M | ---- | 23.63%151.14M | ---- | 98.48%122.25M | 96.37%54.26M | 42.19%61.59M | --27.63M | -48.82%43.32M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | -64.69%-21.46M | ---- | -436.13%-13.03M | ---- | 42.03%-2.43M | 105.33%4.55M | 58.00%-4.19M | --2.21M | -25.93%-9.98M |
| Attributable subsidiary (profit) loss | ---- | 1,684.93%1.16M | ---- | 63.68%-73K | ---- | 35.99%-201K | -195.71%-207K | -1,465.22%-314K | ---70K | -52.08%23K |
| Impairment and provisions: | ---- | -105.73%-52K | ---- | -44.97%908K | ---- | 281.72%1.65M | -102.38%-316K | -114.71%-908K | --13.29M | -48.91%6.17M |
| -Other impairments and provisions | ---- | -105.73%-52K | ---- | -44.97%908K | ---- | 281.72%1.65M | -102.38%-316K | -114.71%-908K | --13.29M | -48.91%6.17M |
| Revaluation surplus: | ---- | -29.81%-20.23M | ---- | 20.44%-15.59M | ---- | -31.84%-19.59M | -51.06%-9.66M | -71.28%-14.86M | ---6.39M | 10.48%-8.67M |
| -Other fair value changes | ---- | -29.81%-20.23M | ---- | 20.44%-15.59M | ---- | -31.84%-19.59M | -51.06%-9.66M | -71.28%-14.86M | ---6.39M | 10.48%-8.67M |
| Asset sale loss (gain): | ---- | -194.74%-198K | ---- | 102.44%209K | ---- | -1,226.54%-8.57M | -1,834.17%-5.53M | -59.88%761K | --319K | 47,325.00%1.9M |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | ---- | ---6.87M | ---6M | ---- | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | ---- | -194.74%-198K | ---- | 112.25%209K | ---- | -324.18%-1.71M | 46.71%468K | -59.88%761K | --319K | 47,325.00%1.9M |
| Depreciation and amortization: | ---- | 18.67%106.6M | ---- | 20.25%89.83M | ---- | 19.26%74.7M | 22.34%36.4M | 5.01%62.64M | --29.75M | -1.95%59.65M |
| -Depreciation | ---- | 18.63%108.82M | ---- | 21.63%91.73M | ---- | 18.94%75.41M | 23.24%36.99M | 6.07%63.4M | --30.01M | -1.74%59.78M |
| -Other depreciation and amortization | ---- | -17.01%-2.22M | ---- | -167.84%-1.9M | ---- | 7.32%-709K | -125.57%-591K | -493.02%-765K | ---262K | ---129K |
| Financial expense | ---- | ---- | ---- | ---- | ---- | -48.42%3.74M | ---- | 4,109.88%7.24M | ---- | --172K |
| Exchange Loss (gain) | ---- | 10.06%-733K | ---- | 27.30%-815K | ---- | -7,106.25%-1.12M | -482.86%-408K | -97.82%16K | ---70K | 396.76%733K |
| Special items | ---- | 111.10%37.92M | ---- | --17.97M | ---- | ---- | ---- | ---- | ---- | ---- |
| Operating profit before the change of operating capital | ---- | -0.92%228.44M | ---- | 35.28%230.55M | ---- | 52.19%170.42M | 18.62%79.08M | 20.01%111.98M | --66.67M | -33.23%93.31M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | -125.59%-49.04M | ---- | 432.71%191.64M | ---- | 67.94%-57.6M | -74.59%-30.82M | -144.17%-179.65M | ---17.65M | -952.82%-73.57M |
| Accounts receivable (increase)decrease | ---- | -712.09%-186.07M | ---- | 67.46%-22.91M | ---- | 74.27%-70.41M | 76.82%-43.53M | -1,700.67%-273.68M | ---187.79M | 351.81%17.1M |
| Accounts payable increase (decrease) | ---- | 142.24%55.85M | ---- | -128.74%-132.21M | ---- | 19.58%459.96M | 19.30%313.64M | 14,236.08%384.64M | --262.9M | -95.01%2.68M |
| Special items for working capital changes | ---- | -121.42%-80.56M | ---- | -223.40%-36.38M | ---- | -111.76%-11.25M | -203.99%-108.02M | 277.15%95.63M | --103.88M | -175.22%-53.98M |
| Cash from business operations | 3,640.79%817.55M | -113.60%-31.38M | -62.35%21.86M | -53.03%230.68M | -72.41%58.05M | 253.54%491.12M | -7.74%210.35M | 1,060.43%138.92M | --228M | -105.42%-14.46M |
| China income tax paid | ---- | ---- | ---- | ---- | ---- | ---- | -16.33%-2.26M | ---- | ---1.94M | ---- |
| Other taxs | -474.17%-12.45M | -272.99%-10.14M | 17.22%-2.17M | -19.74%-2.72M | ---2.62M | 15.01%-2.27M | ---- | -0.98%-2.67M | ---- | ---2.65M |
| Interest received - operating | -56.51%10.41M | 17.57%38.4M | 87.86%23.93M | 55.25%32.66M | 105.14%12.74M | 158.36%21.04M | 53.45%6.21M | 20.85%8.14M | --4.05M | -26.93%6.74M |
| Net cash from operations | 1,769.62%815.51M | -101.20%-3.12M | -36.01%43.62M | -48.89%260.63M | -68.19%68.17M | 253.14%509.89M | -6.87%214.3M | 1,492.23%144.39M | --230.11M | -103.84%-10.37M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | 417.57%4.51M | 114.33%5.04M | 4.19%871K | -49.17%2.35M | -64.71%836K | 14.34%4.63M | 2,532.22%2.37M | -51.62%4.05M | --90K | 52.94%8.36M |
| Loan receivable (increase) decrease | ---- | ---- | ---- | -97.22%2.29M | -96.79%2.29M | 209.24%82.37M | 1,690.61%71.36M | 1,866.25%26.64M | --3.99M | 98.24%-1.51M |
| Decrease in deposits (increase) | -197.42%-175.1M | 35.75%-80.05M | 57.32%-58.87M | -61.40%-124.6M | -11,595.00%-137.94M | -141.25%-77.2M | 108.63%1.2M | -33.81%-32M | ---13.9M | 63.21%-23.91M |
| Sale of fixed assets | -8.26%533K | 640.30%1.95M | 552.81%581K | -92.62%263K | 21.92%89K | 1,755.21%3.56M | 55.32%73K | 5.49%192K | --47K | -12.92%182K |
| Purchase of fixed assets | 1.64%-137.32M | -113.17%-433.38M | 9.66%-139.62M | 9.37%-203.3M | -25.55%-154.54M | 29.26%-224.33M | 21.32%-123.1M | -295.03%-317.11M | ---156.45M | -121.23%-80.28M |
| Purchase of intangible assets | ---- | ---- | ---41.8M | ---- | ---- | 67.62%-9.39M | 67.62%-9.39M | -417.86%-29M | ---29M | 70.83%-5.6M |
| Sale of subsidiaries | --324K | ---- | ---- | ---- | ---- | -86.94%5.87M | --5M | --44.94M | ---- | ---- |
| Recovery of cash from investments | -35.51%388.95M | 265.79%1.21B | 25.30%603.09M | 67.27%331.79M | 416.60%481.31M | -76.85%198.36M | -73.37%93.17M | -48.39%856.96M | --349.8M | -42.49%1.66B |
| Cash on investment | -14.98%-581.42M | -254.66%-1.16B | 0.00%-505.65M | -14.69%-327.97M | -123.56%-505.65M | 74.57%-285.95M | 64.80%-226.18M | 29.84%-1.12B | ---642.47M | 45.04%-1.6B |
| Other items in the investment business | 237.51%9.62M | -13.08%7.3M | -60.50%2.85M | 4.99%8.4M | --7.22M | 6.91%8M | ---- | -47.35%7.48M | --2M | --14.21M |
| Net cash from investment operations | -253.60%-489.91M | -44.36%-448.64M | 54.78%-138.55M | -5.67%-310.78M | -65.17%-306.4M | 47.72%-294.1M | 61.82%-185.5M | -1,710.97%-562.52M | ---485.9M | 86.49%-31.06M |
| Net cash before financing | 443.01%325.61M | -800.79%-451.76M | 60.15%-94.93M | -123.24%-50.15M | -927.07%-238.23M | 151.61%215.8M | 111.26%28.8M | -909.18%-418.13M | ---255.79M | -203.33%-41.43M |
| Cash flow from financing activities | ||||||||||
| New borrowing | 39.46%1.37B | 31.72%1.58B | 76.59%980.24M | 31.43%1.2B | 10.79%555.11M | -4.26%913.36M | 30.97%501.03M | 46.92%953.96M | --382.57M | 107.77%649.29M |
| Refund | -67.43%-1.11B | -0.66%-1.22B | -153.00%-661.44M | -31.07%-1.21B | 27.97%-261.44M | -96.68%-926.16M | -182.83%-362.97M | 25.08%-470.89M | ---128.34M | -61.02%-628.49M |
| Issuing shares | ---- | ---- | ---- | --699.58M | ---- | ---- | ---- | ---- | ---- | ---- |
| Interest paid - financing | 14.87%-9.68M | -1.72%-21.91M | -4.19%-11.37M | 12.56%-21.54M | 15.93%-10.92M | -68.77%-24.63M | -79.25%-12.98M | -118.99%-14.6M | ---7.24M | 5.43%-6.67M |
| Dividends paid - financing | ---56.63M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Issuance expenses and redemption of securities expenses | ---- | -2,796.13%-183.5M | -1,590.89%-51.22M | -40.80%-6.34M | ---3.03M | ---4.5M | ---- | ---- | ---- | ---- |
| Other items of the financing business | ---6.45M | ---137.06M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Adjustment item of financing business | ---- | ---- | ---- | ---- | ---- | ---- | ---1.13M | ---- | ---- | ---- |
| Net cash from financing operations | -29.02%180.46M | -98.03%12.91M | -8.53%254.22M | 1,559.32%654.71M | 126.63%277.92M | -109.65%-44.86M | -49.98%122.63M | 5,453.11%464.85M | --245.18M | 108.70%8.37M |
| Effect of rate | -105.70%-336K | 65.07%-1.62M | 2,184.11%5.89M | -321.06%-4.63M | -34.35%258K | 2,892.00%2.09M | 555.00%393K | 93.00%-75K | --60K | -924.62%-1.07M |
| Net Cash | 217.69%506.06M | -172.59%-438.85M | 301.38%159.29M | 253.68%604.56M | -73.79%39.69M | 265.89%170.93M | 1,527.68%151.43M | 241.30%46.72M | ---10.61M | 41.05%-33.06M |
| Begining period cash | -44.27%554.51M | 151.87%994.97M | 151.87%994.97M | 77.94%395.04M | 77.94%395.04M | 26.60%222.01M | 26.60%222.01M | -16.29%175.37M | --175.37M | -21.08%209.5M |
| Cash at the end | -8.61%1.06B | -44.27%554.51M | 166.71%1.16B | 151.87%994.97M | 16.36%434.98M | 77.94%395.04M | 126.81%373.84M | 26.60%222.01M | --164.82M | -16.29%175.37M |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.